Personal Electronic Health Records in Improving Screening Rates for Colorectal Cancer

NCT01032746 | Unknown

• 2 other identifiers: CDR0000661288HMS-11960
• Study Type: interventional
• Target: 1,000
• Locations: 1 country
• Sites: 2

Brief Summary

RATIONALE: Use of a web-based risk assessment tool may help improve screening rates for colorectal cancer. PURPOSE: This randomized clinical trial is studying personal electronic health records to see how well they work in improving screening rates for colorectal cancer.

Conditions

Colorectal Cancer

Keywords

colon cancer; rectal cancer

Outcome Measures

Primary Outcomes (1)

• Receipt of colorectal cancer screening exam (fecal occult blood test, flexible sigmoidoscopy, or colonoscopy) within 4 months following delivery of an electronic message within the personal health record

Secondary Outcomes (2)

• Proportion of participants who access the web-based risk-assessment tool

• Distribution of risk-status among participants who complete the web-based risk-assessment tool

Interventions

educational intervention OTHER

internet-based intervention OTHER

evaluation of cancer risk factors PROCEDURE

fecal occult blood test PROCEDURE

screening colonoscopy PROCEDURE

Eligibility Criteria

• Age: 50 Years - 75 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

DISEASE CHARACTERISTICS: * Overdue for colorectal cancer screening (identified using automated extracts from the electronic medical record), as defined by the following criteria: * No fecal occult blood test within the past 12 months * No flexible sigmoidoscopy within the past 5 years * No colonoscopy within the past 10 years * Receiving primary care at a Harvard Vanguard Medical Associates (HVMA) center * Registered to use the HVMA patient portal (MyHealth) AND has an active MyHealth account PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * See Disease Characteristics

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

• Harvard University: lead
• National Cancer Institute (NCI): collaborator

Study Sites (2)

Harvard Medical School

Boston, Massachusetts, 02115, United States

RECRUITING

Harvard Vanguard Medical Associates - Kenmore

Boston, Massachusetts, 02215, United States

RECRUITING

Related Publications (1)

• Sequist TD, Zaslavsky AM, Colditz GA, Ayanian JZ. Electronic patient messages to promote colorectal cancer screening: a randomized controlled trial. Arch Intern Med. 2011 Apr 11;171(7):636-41. doi: 10.1001/archinternmed.2010.467. Epub 2010 Dec 13.

  PMID: 21149743 RESULT

MeSH Terms

Conditions

Colorectal Neoplasms; Colonic Neoplasms; Rectal Neoplasms

Interventions

Early Intervention, Educational; Occult Blood

Condition Hierarchy (Ancestors)

Intestinal Neoplasms; Gastrointestinal Neoplasms; Digestive System Neoplasms; Neoplasms by Site; Neoplasms; Digestive System Diseases; Gastrointestinal Diseases; Colonic Diseases; Intestinal Diseases; Rectal Diseases

Intervention Hierarchy (Ancestors)

Child Health Services; Community Health Services; Health Services; Health Care Facilities Workforce and Services; Preventive Health Services; Clinical Laboratory Techniques; Diagnostic Techniques and Procedures; Diagnosis; Investigative Techniques

Study Officials

• John Ayanian, MD, MPP

  Harvard Medical School (HMS and HSDM)

  STUDY CHAIR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Purpose: SCREENING
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: December 13, 2009
• First Posted: December 15, 2009
• Study Start: March 1, 2005
• Primary Completion: September 1, 2010
• Last Updated: December 18, 2013

Record last verified: 2011-06

Locations

US (2)